Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05873634 · ClinicalTrials.gov registry record

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

A clinical trial of Heart Failure and Heart Failure With Preserved Ejection Fraction, sponsored by Northwestern University.

Recruiting
Registry status
1,000
Enrollment target
6
Study locations

NCT05873634 is a study of Heart Failure and Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 1,000 participants, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (51% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05873634, a study of Heart Failure and Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
1,000 participants
Enrollment target
6
Study locations

Study Summary

HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands of the body, resulting in shortness of breath, fluid retention, and fatigue. HeartShare aims to better classify heart failure into subtypes to help develop more personalized treatments for patients, with the hope that this will improve the lives of heart failure patients. To do this, HeartShare is bringing together a large amount of data (including images, such as heart ultrasounds and MRIs and molecular data from the blood, such as genetics) from previously conducted studies and electronic health records, and is gathering new data through participants enrolled in the HeartShare Deep Phenotyping Study.

Conditions Studied

Heart Failure Heart Failure With Preserved Ejection Fraction

Study Locations (6)

California

  • University of California Davis - Sacramento

Illinois

  • Northwestern University - Chicago

Massachusetts

  • Mass General Brigham - Boston

Minnesota

  • Mayo Clinic - Rochester

North Carolina

  • Wake Forest University - Winston-Salem

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2023-03-01
Est. Completion 2026-06

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05873634

The ClinicalTrials.gov registry entry for NCT05873634 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (51% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.

NCT05873634 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05873634 about?

NCT05873634 is a clinical study titled "HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets". HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands of the body, resulting in shortness of breath, fluid retention, and fatigue. HeartShare aims to better classify heart failure into subtypes t...

What is the current status of trial NCT05873634?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-03-01. Estimated completion is 2026-06.

What conditions does trial NCT05873634 study?

This clinical trial studies the following conditions: Heart Failure, Heart Failure With Preserved Ejection Fraction.

Who is sponsoring clinical trial NCT05873634?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05873634 being conducted?

This trial has 6 study locations across California, Illinois, Massachusetts, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Heart Failure With Preserved Ejection Fraction

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.